BUSINESS● LOW1h ago · Sep 8, 2026, 4:28 PM
Biohaven downgraded at RBC Capital Markets after SK Biopharma deal
Seeking Alpha Tech · global
Biohaven's rating was downgraded by RBC Capital Markets following its deal with SK Biopharma. This indicates a significant financial market reaction to a corporate transaction, affecting the company's investment outlook.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS23m agoYieldMax Memory & Storage Portfolio Option Inc ETF declares $0.4155 dividendSeeking Alpha TechBUSINESS28m agoYieldMax® Universe Fund of Option Income ETFs declares $0.0598 dividendSeeking Alpha TechBUSINESS29m agoYieldMax® Magnificent 7 Fund of Option Income ETFs declares $0.0741 dividendSeeking Alpha TechBUSINESS29m agoYieldMax Ultra Option Income Strategy ETF declares $0.3044 dividendSeeking Alpha Tech